[go: up one dir, main page]

KR920019784A - 벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약제로서의 용도 - Google Patents

벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약제로서의 용도 Download PDF

Info

Publication number
KR920019784A
KR920019784A KR1019920007140A KR920007140A KR920019784A KR 920019784 A KR920019784 A KR 920019784A KR 1019920007140 A KR1019920007140 A KR 1019920007140A KR 920007140 A KR920007140 A KR 920007140A KR 920019784 A KR920019784 A KR 920019784A
Authority
KR
South Korea
Prior art keywords
compound
hydrogen
lower alkyl
formula
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019920007140A
Other languages
English (en)
Other versions
KR100215345B1 (ko
Inventor
제이. 흐리브 니콜라스
지. 저칵 존
Original Assignee
빅터 제이. 바우어
훽스트-러셀 파마슈티칼즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 빅터 제이. 바우어, 훽스트-러셀 파마슈티칼즈 인코포레이티드 filed Critical 빅터 제이. 바우어
Publication of KR920019784A publication Critical patent/KR920019784A/ko
Application granted granted Critical
Publication of KR100215345B1 publication Critical patent/KR100215345B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

내용 없음

Description

벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약조제로서의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. 일반식 (I)의 화합물, 이의 기하 및 광학 이성체 또는 약제학적으로 허용되는 이의 염.
    상기식에서, R1은 수소 또는 저급 알킬이고, R2는 저급 알킬이거나,
    그룹이고, R3은 수소 또는 저급 알킬이고, A는 저급 알킬렌이거나, 일반식 -CHR4CH=CHCHR4-또는-CHR4C=CHR4-의 그룹이고, R4는 수소 또는 저급 알킬이고, R4는 수소 또는 저급 알킬이고, X는 O또는 S이고, W는 N 또는 CH이고, Y는 수소, 저급 알킬, 저급 알콕시, 하이드록시, 할로겐 또는 트리플루오로메틸이고, Z는 수소, 저급 알킬, 저급 알콕시, 하이드록시, 할로겐 또는 트리플루오로메틸이고, n은 1 또는 2이며, 실선(-)은 일반식의 지시된 원소에 대한 그룹의 부착점을 나타낸다.
  2. 제1항에 있어서, Y가 수소이고 Z는 수소, 저급 알콕시 또는 할로겐이며 n이 1인 화합물.
  3. 제2항에 있어서, X가 S이고 A가 C1-C4알킬렌이며 R2가 일반식.
    〔여기서, Z는 수소, 메톡시 또는 플루오로이다〕의 그룹인 화합물.
  4. 제1항에 있어서, N-메틸-N-〔4-(1-(2-메톡시페닐)-4-피페라지닐)부틸〕-1,2-벤즈이소티아졸-3-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
  5. 제1항에 있어서, N-메틸-N-〔4-(1-(6-플로오로벤조〔b〕티오펜-3-일)-4-피페라진-일)부틸〕-1,2-벤즈이소티아졸-3-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
  6. 제1항에 있어서, N-메틸-N-〔4-(1-(6-플로오로-1,2-벤조이소옥사졸-3-일)-4-피페라진-일)부틸〕-1,2-벤즈이소티아졸-3-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
  7. 제1항에 있어서, N-〔2-(1-(4-플루오로벤조일-4-피페라지닐)에틸〕-1,2-벤즈이소티아졸-3-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
  8. 제1항에 있어서, N-메틸-N-〔4-(1-(1,2-벤조이소옥사졸-3-일)-4-피페라진-일)부틸〕-1,2-벤즈이소티아졸-3-카복스아미드 또는 약제학적으로 허용되는 이의 염인 화합물.
  9. 활성 성분으로서 제1항에서 정의한 바와 같은 화합물 및 이의 적합한 담체를 포함하는 약제학적 조성물.
  10. 항정신병적 활성을 갖는 약제를 제조하기 위한 제1항의 화합물의 용도.
  11. a)일반식(I)의 화합물을 일반식(2)의 화합물과 반응시키거나, b)일반식(3)의 화합물을 일반식(2a)의 화합물과 반응시킴을 포함하는, 제1항의 화합물의 제조방법.
    상기식에서, R1, R2, A, X, Y, W 및 n은 제1항에서 정의한 바와 같고, R1은 클로로, 브로모 또는 요오도이거나, 그를 OSO2R6〔여기서, R6은 알킬, 페닐 또는 톨릴이다〕이며, Hal은 클로로 또는 브로모이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920007140A 1991-04-29 1992-04-28 벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약제로서의 용도 Expired - Fee Related KR100215345B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7/693,168 1991-04-29
US07/693,168 1991-04-29
US90/002891A US5143923B1 (en) 1991-04-29 1991-04-29 Benzoisothiazole-and benzisoxazole-3-carboxamides

Publications (2)

Publication Number Publication Date
KR920019784A true KR920019784A (ko) 1992-11-20
KR100215345B1 KR100215345B1 (ko) 1999-08-16

Family

ID=24783602

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920007140A Expired - Fee Related KR100215345B1 (ko) 1991-04-29 1992-04-28 벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약제로서의 용도

Country Status (21)

Country Link
US (1) US5143923B1 (ko)
EP (1) EP0511610B1 (ko)
JP (1) JP2656189B2 (ko)
KR (1) KR100215345B1 (ko)
AT (1) ATE142628T1 (ko)
AU (1) AU644054B2 (ko)
CA (1) CA2067404C (ko)
CZ (1) CZ282764B6 (ko)
DE (1) DE69213544T2 (ko)
DK (1) DK0511610T3 (ko)
ES (1) ES2094843T3 (ko)
FI (1) FI921875L (ko)
GR (1) GR3021211T3 (ko)
HU (1) HU214032B (ko)
IE (1) IE77036B1 (ko)
IL (1) IL101700A (ko)
MX (1) MX9201963A (ko)
NO (1) NO180488C (ko)
NZ (1) NZ242479A (ko)
PL (2) PL168090B1 (ko)
RU (1) RU2039057C1 (ko)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378714A (en) * 1991-11-27 1995-01-03 Novo Nordisk A/S Antipsychotic piperidine derivatives
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
US5240927A (en) * 1992-05-19 1993-08-31 Hoechst-Roussel Pharmaceuticals Incorporated Benzo[β]thiophen-3-yl piperazines as antipsychotic agents
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
GB9302622D0 (en) * 1993-02-10 1993-03-24 Wellcome Found Heteroaromatic compounds
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
GB9603457D0 (ko) * 1996-02-19 1996-04-17 Merck & Co Inc
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
US5952351A (en) * 1995-02-23 1999-09-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
EP0812318B1 (en) 1995-02-28 2006-02-08 H. Lundbeck A/S 4-aminotetrahydrobenzisoxazole or -isothiazole compounds
EP0732332B1 (en) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
GB9716101D0 (en) * 1997-07-30 1997-10-01 Pharmacia & Upjohn Spa Fused heterocyclic compounds
US6339087B1 (en) * 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
JP3475177B2 (ja) * 1998-11-17 2003-12-08 エフ．ホフマン−ラ ロシュ アーゲー ４−アロイルピペリジンｃｃｒ−３受容体拮抗剤ｉｉｉ
CA2351631A1 (en) 1998-11-20 2000-06-02 F. Hoffmann-La Roche Ag Piperidine quaternary salts-ccr-3 receptor antagonists
EP1165545A1 (en) * 1999-03-26 2002-01-02 AstraZeneca AB Novel compounds
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
KR100901221B1 (ko) 2000-04-28 2009-06-08 아카디아 파마슈티칼스 인코포레이티드 무스카린성 작용제
EP1535912A1 (en) * 2000-04-28 2005-06-01 Arcadia Pharmaceuticals Inc. Muscarinic agonists
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) * 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
EP1935887B1 (en) 2001-02-16 2010-01-13 Aventis Pharmaceuticals, Inc. Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
GB0117899D0 (en) * 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
SE0102809D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab Novel compounds
AU2003267201B2 (en) * 2002-09-14 2009-04-23 The Gov't Of The U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services Structurally rigid dopamine D3 receptor selective ligands and process for making them
PL375981A1 (en) * 2002-09-17 2005-12-12 Warner-Lambert Company Llc Heterocyclic substituted piperazines for the treatment of schizophrenia
US20040127501A1 (en) * 2002-09-24 2004-07-01 Zhengming Chen Therapeutic agents useful for treating pain
WO2005040129A2 (en) * 2003-10-24 2005-05-06 F. Hoffmann-La Roche Ag Ccr3 receptor antagonists
US20160296146A9 (en) * 2006-06-29 2016-10-13 Fred Wood Apparatus-Mounted Vein Contrast Enchancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2626260A (en) * 1951-09-05 1953-01-20 Sterling Drug Inc Nitrobenzisoxazoles
US3145215A (en) * 1961-12-19 1964-08-18 Sterling Drug Inc Indazole derivatives
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
US4021552A (en) * 1975-06-27 1977-05-03 A. H. Robins Company, Incorporated 10-[ω-(BENZOYLPIPERIDINYL)ALKYL]PHENOTHIAZINES
US4327103A (en) * 1980-07-07 1982-04-27 Hoechst-Roussel Pharmaceuticals Incorporated 3-{3-[4-(4-Fluorobenzoyl)piperidyl]propyl}-2-methyl indole
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
IL66866A (en) * 1982-04-09 1987-08-31 Hoechst Roussel Pharma 1-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituted)-piperazines and-piperidines,a process for the preparation thereof,and pharmaceutical compositions containing them
NZ209876A (en) * 1983-10-17 1988-03-30 Duphar Int Res Piperazines and pharmaceutical compositions
CH667657A5 (de) * 1985-01-07 1988-10-31 Sandoz Ag Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
JPS61219950A (ja) * 1985-03-26 1986-09-30 Fuji Photo Film Co Ltd 熱現像感光材料
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
EP0200444B1 (en) * 1985-04-27 1992-11-11 Beecham Group Plc Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity
GB8623142D0 (en) * 1986-09-26 1986-10-29 Beecham Group Plc Compounds
FR2616149B1 (fr) * 1987-06-04 1990-10-19 Adir Nouveau derive de l'acide benzo (b) thiophene - 7 carboxylique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
DE3827253A1 (de) * 1987-08-20 1989-03-02 Sandoz Ag Ester und amide von cyclischen carbonsaeuren und cyclischen alkoholen und aminen sowie verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
IL90279A (en) * 1988-05-24 1995-03-30 American Home Prod Piperazinyl carboxamide derivatives, their preparation and pharmaceutical com¦ositions containing them
GB8900382D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
US5114936A (en) * 1990-08-23 1992-05-19 Hoechst-Roussel Pharmaceuticals Incorporated 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use

Also Published As

Publication number Publication date
PL168090B1 (pl) 1996-01-31
NO921654D0 (no) 1992-04-28
HU214032B (en) 1997-12-29
JPH05132472A (ja) 1993-05-28
CZ282764B6 (cs) 1997-10-15
EP0511610B1 (en) 1996-09-11
US5143923B1 (en) 1993-11-02
HUT62889A (en) 1993-06-28
RU2039057C1 (ru) 1995-07-09
NO180488C (no) 1997-04-30
HU9201414D0 (en) 1992-07-28
CA2067404A1 (en) 1992-10-30
NZ242479A (en) 1995-02-24
EP0511610A1 (en) 1992-11-04
FI921875A0 (fi) 1992-04-27
IL101700A (en) 1995-11-27
KR100215345B1 (ko) 1999-08-16
PL294358A1 (en) 1993-08-09
IE77036B1 (en) 1997-11-19
ES2094843T3 (es) 1997-02-01
US5143923A (en) 1992-09-01
AU1518792A (en) 1992-11-05
CS129892A3 (en) 1992-11-18
NO180488B (no) 1997-01-20
AU644054B2 (en) 1993-12-02
MX9201963A (es) 1992-11-01
DK0511610T3 (ko) 1997-06-16
PL168870B1 (pl) 1996-04-30
DE69213544D1 (de) 1996-10-17
GR3021211T3 (en) 1996-12-31
DE69213544T2 (de) 1997-02-27
CA2067404C (en) 2003-08-19
JP2656189B2 (ja) 1997-09-24
FI921875L (fi) 1992-10-30
ATE142628T1 (de) 1996-09-15
NO921654L (no) 1992-10-30
IL101700A0 (en) 1992-12-30
IE921379A1 (en) 1992-11-04

Similar Documents

Publication Publication Date Title
KR920019784A (ko) 벤조이소티아졸 및 벤조이소옥사졸-3-카복스아미드, 이의 제조방법 및 약제로서의 용도
RU2379299C2 (ru) Производные 5-(бенз-(z)-илиден)тиазолидин-4-она и их применение в качестве иммуносупрессорных агентов
RU2312106C2 (ru) Замещенные 4-алкоксиоксазолпроизводные в качестве агонистов ppar
NO934740L (no) Forbindinger vedrörende benzotiofener
KR890003742A (ko) 카르바모일키롤리돈 유도체 및 노인성 치매용 약제
ATE50256T1 (de) Hypoglycemische thiazolidinedione.
RU96115142A (ru) Производные 5-(2-имидазолиниламино)бензимидазола, их получение и применение в качестве агонистов альфа-2-адреноцепторов
JP2003502369A5 (ko)
ATE542805T1 (de) Ppar-delta aktivatoren
RU93005057A (ru) Фармацевтические соединения, производные тиенобензодиазепина, способ их получения, фармкомпозиция и их использование
PT87073A (pt) 4-]4-]4-]4-]]2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1,3-dioxolan-4-yl"methoxy"phenyl"-1-piperazinyl"phenyl"triazolones
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
KR930000483A (ko) [(아릴알킬피페리딘-4-일)메틸]-2a,3,4,5-테트라 하이드로-1(2H)-아세나프틸렌-1-온 및 관련 화합물, 이의 제조방법 및 약제로서의 이의 용도
ATE158795T1 (de) Thiazolidindionderivate, ihre herstellung und anwendung
KR920016452A (ko) N-(아릴옥시알킬)헤테로아릴-8-아자비시클로[3.2.1]옥탄, 중간체, 이의 제조방법 및 약제로서 이의 용도
ATE95816T1 (de) 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung.
ATE111460T1 (de) 2-(aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre herstellung und ihre anwendung in der therapeutik.
KR920007995A (ko) 벤즈아미드 유도체
ATE28862T1 (de) Aktive kompositionen gegen motten, weisse fliegen und holzwuermer, pharmazeutische kompositionen und benzoylharnstoffderivaten.
KR940005621A (ko) 벤조[b]티오펜-3-일-피페라진. 이의 제조방법 및 약제로서 이의 용도
KR920012060A (ko) 치환된 n-벤조일-n'-(2-페닐에틸)-피페라진
KR910020007A (ko) 3-[1-티아졸리디닐부틸-4-피페라지닐]-1h-인다졸, 이의 제조방법 및 이의 약제로서의 용도
KR930021629A (ko) 피페라진 유도체
DK0476854T3 (da) Farmaceutisk komposition til at hæmme blodpladeaggregation

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19920428

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19970416

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19920428

Comment text: Patent Application

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19990225

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19990524

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19990525

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20020517

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20030519

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20030519

Start annual number: 5

End annual number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20050207